Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma

NCT00413192 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00413192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00413192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma
Lead sponsor
Eisai Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2007
Completion date
February 28, 2013
Enrollment
128 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

soft tissue sarcoma